Benicar HTC Lawsuit Settlements & Claims

Print this page

FDA warns that patients using blood-pressure medication Benicar are put at risk of suffering crippling intestinal side effects from sprue-like enteropathy. New lawsuits are being filed for victims of rare gastrointestinal disease identified as side effect from Benicar HCT, Azor, and Tribenzor.

If you or a loved one have suffered a serious gastrointestinal disease known as sprue-like enteropathy from the use of Benicar or other blood-thinners contact our national network of attorneys as soon as possible to ensure your legal right to file a Benicar class action lawsuit and seek compensation for your condition. There could be large cash settlements from these claims.

The crippling consequences of this horrible side effect are severe or continual diarrhea, significant weight loss and devastating physical and mental harm for which compensation is now being sought on behalf of victims.

The U.S. Food and Drug Administration has issued a National Drug Safety Communication warning that the blood pressure drug olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause these severe intestinal problems. The link between the medications and this rare disease was first uncovered by medical researchers at the renown Mayo Clinic.

Our experienced, aggressive lawyers are now investigating claims from Benicar-induced sprue-like enteropathy patients who have suffered serious life-changing side effects caused by this product. Please contact us as soon as possible to ensure that all of your legal rights are protected.

There may be time limits involved in certain cases and the earlier you contact us the more effectively we can begin pursuing compensation for Benicar-induced sprue-like enteropathy in which eligibility is determined.

Free consultations are being offered to advise families about the legal options that may be available to them in seeking compensation for medical costs, pain and suffering or other expenses that may have been incurred as a result of severe gastrointestinal problems caused by the use of Benicar as a blood-thinner.

WHAT IS SPRUE-LIKE ENTEROPATHY?


This rare gastrointestinal condition is caused by damage to the villi, tiny, finger-like protrusions of tissue in the intestines which play a valuable role by increasing the surface area and assisting in nutrient absorption and transporting substances into the blood stream.

Sprue-like enteropathy is defined by symptoms that include severe, chronic diarrhea and substantial weight loss that weakens the victim and causes constant physical and emotional stress.

The link between Benicar and similar blood-thinners and this condition was first uncovered by medical experts at the Mayo Clinic, who were researching Benicar in connection with celiac disease but found that gastrointestinal symptoms significantly decreased after the discontinuation of their treatment with Benicar.

The research intensified after that with increasing numbers of patients and eventually through trial and error determined that there was a definable link between the blood-thinner and sprue-like enteropathy, according to published medical literature.
The FDA followed up on these findings by reporting to patients and physicians that Benicar's label warnings were being updated in 2013 to inform them about the research and its ramifications.

Physicians are now warning patients that sprue-like enteropathy may develop months to years after beginning treatment with blood-thinners containing olmesartan, and that hospitalization may be required.

Have you experienced these devastating symptoms or been caring for a loved one suffering from them? If so you may be eligible for cash compensation.

To ensure all of your legal options please contact our experienced, aggressive Benicar-induced sprue-like enteropathy lawyers as soon as possible for a free consultation about what avenues of compensation may be available in your case..

WHAT IS THE FDA NATIONAL HEALTH WARNING ABOUT BENICAR?

Here is the July 3, 2013 National Safety Announcement to patients and physicians warning about the medical research link that was discovered involving Benicar and similar blood-thinners and sprue-like enteropathy:

The U.S. Food and Drug Administration (FDA) is warning that the blood pressure drug olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy.  FDA has approved changes to the labels of these drugs to include this concern.

Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. The enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization (see Data Summary). If patients taking olmesartan develop these symptoms and no other cause is found, the drug should be discontinued, and therapy with another antihypertensive started. Discontinuation of olmesartan has resulted in clinical improvement of sprue-like enteropathy symptoms in all patients.

Olmesartan medoxomil is an angiotensin II receptor blocker (ARB) approved for the treatment of high blood pressure, alone or with other antihypertensive agents, and is one of eight marketed ARB drugs.  Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan.

FDA will continue to evaluate the safety of olmesartan-containing products and will communicate again if additional information becomes available.

Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. The enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization (see Data Summary). If patients taking olmesartan develop these symptoms and no other cause is found, the drug should be discontinued, and therapy with another antihypertensive started. Discontinuation of olmesartan has resulted in clinical improvement of sprue-like enteropathy symptoms in all patients.

Have you experienced these devastating symptoms or been caring for a loved one suffering from them? If so you may be eligible for cash compensation.

To ensure all of your legal options please contact our experienced, aggressive Benicar-induced sprue-like enteropathy lawyers as soon as possible for a free consultation about what avenues of compensation may be available in your case.

WHAT IS BENICAR HTC?

The FDA approved Benicar in 2002 for the treatment of high blood pressure in adults. The FDA says Benicar (also known as olmesartan) is in the class of drugs called angiotensin II receptor blockers (ARBs). These drugs and a closely related group of drugs called angiotensin-converting enzyme inhibitors (ACEIs) have been evaluated in many studies involving thousands of patients at high-risk for cardiovascular events, such as patients who had a previous heart attack or had heart failure. Benicar is also sold in combination with hydrocholorothiazide as Benicar HCT for the treatment of high blood pressure.

Lowering blood pressure is a vital function of some medications to lower the risk of patients suffering fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

However, as is the case with all medications, there is the possibility of patients suffering serious side effects. In the case of Benicar the FDA has ordered that new warnings be put on the medication's label to alert patients to (FDA) is warn  Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like enteropathy.

If you or a loved one has suffered sprue-like enteropathy from the use of these medications please contact our national network of lawyers for a free consultation about your rights to seek compensation.

Our attorneys are well versed in the intricacies of pharmaceutical law and are offering free consultations to determine the merits of your case and whether you are eligible to file Benicar sprue-like enteropathy lawsuit. Please contact us as soon as possible to ensure ALL of your legal rights.

HOW TO FILE A BENICAR SPRUE-LIKE ENTEROPATHY LAWSUIT

Our nationwide legal team will make it easy for you to file your Benicar sprue-like enteropathy claim because of the experience they have in handling cases similar to the one about which you are inquiring.

The first step is to take advantage of the free consultations we are offering in order to review your eligibility to file a claim.


If you or a loved one has suffered any serious health problems as a result of being treated with Benicar or similar medications we urge you to contact us as soon as possible for experienced, aggressive legal representation seeking the compensation you may be due, dependent upon the facts of your case.

Keep in mind that there may be legal time limits involved and the facts of each case may differ so it is important that you contact our aggressive legal team as soon as possible in order to preserve all of your legal options in a Benicar sprue-like enteropathy therapy case.

 

blog comments powered by Disqus
  • - -
  • By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.

What People are Saying

User
Lucille says:

I took foxamax from and have suffered 8 compressed back fractures..

Topic: Fosomax more
User
Daniela says:

After I started using Yasmin, I experienced chest pains and breathing problems..

Topic: Fosomax more

Cases we handle

From Our Blog

Home | Sitemap 1 | Sitemap 2 | Sitemap 3

Website Design & Web Positioning by Wise Law Group

Copyright ©2013 Resource 4 The People - All rights reserved


Terms of Use

Visit my Google+ Page Legal Resources for the people


Benicar HTC lawsuits and settlements claims page updated on 4/23/2014